The pharmaceutical companies Pfizer and Valneva say their vaccine shows promising results, as they seek Food and Drug ...

Pfizer is working to get approval on a new vaccine that could protect people against Lyme disease. WBZ-TV's Mike Sullivan ...

The vaccine demonstrated a reduction in the rate of infections, but fell short of a key statistical requirement.

Lyme disease infects hundreds of thousands of people each year and now scientists may be on the verge of a breakthrough with ...

Stacey Sager has more on the possible breakthrough in fighting Lyme disease. Pittsburgh Public Schools to go remote during ...

The first human Lyme disease vaccine was 73% effective against the tick-borne illness, says Pfizer. They still plan to seek ...

Earlier this week, pharmaceutical company Pfizer and its partner Valneva announced that an experimental Lyme disease vaccine ...

Pfizer's shot fell short of its trial goal, but with nearly half a million Americans infected each year, the company isn't ...

If approved by regulators, it could become the only Lyme disease vaccine available for people — although it would not be the ...

A Lyme disease vaccine produced by Pfizer and Valneva was deemed 70% effective by the companies after they reviewed the ...

Pfizer and France's Valneva said on Monday their experimental Lyme disease vaccine showed ‌more than 70% efficacy in a ...

Pfizer said its experimental Lyme disease vaccine was more than 70% efficacious in reducing confirmed cases of the tickborne ...